Biotech

All Articles

Lykos will certainly inquire FDA to reevaluate its choice complying with being rejected of MDMA therapy for trauma

.Following an unsatisfactory showing for Lykos Rehabs' MDMA prospect for trauma at a recent FDA cons...

AN 2 fifty percents headcount, stops phase 3 trial after information dissatisfy

.AN2 Therapies is actually reconsidering its organization in feedback to lackluster midphase data, p...

Merck pays for $700M for bispecific, snooping autoimmune position as well as chance to challenge Amgen in cancer

.Merck &amp Co. is actually paying out $700 thousand beforehand to challenge Amgen in a blood cancer...

Gilead pays for J&ampJ $320M to leave licensing bargain for seladelpar

.With Gilead Sciences about to an FDA selection for its own liver ailment drug seladelpar, the busin...

' All hands on deck' at Lilly as peers target being overweight market

.Chief executive officer David Ricks may see the firms setting up outdoors tents at basecamp behind ...

Entero giving up personnel, moving out of workplace as well as stopping R&ampD

.Mattress Liquidators has switched Entero Therapies white as a slab. The collector purchased Entero ...

Exelixis goes down ADC after choosing it's no match for Tivdak

.Exelixis is quiting on its own cells element (TF)- targeting antibody-drug conjugate after concludi...

Relay loses interest in SHP2 prevention after Genentech leaves behind

.3 full weeks after Roche's Genentech system bowed out an SHP2 inhibitor treaty, Relay Therapy has a...

Stoke's Dravet disorder med discharged of predisposed clinical hold

.Stoke Rehabs' Dravet syndrome drug has been actually freed from a partial grip, getting rid of the ...

Fierce Biotech's Gabrielle Masson offers Ferocious 15 at NYSE

.Fierce Biotech Affiliate Editor Gabrielle Masson showed the 2024 training class of Ferocious 15 vic...